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Background: Auditory impairment post stroke is common and may be due to both
peripheral hearing loss and or central auditory processing disorder (CAPD). When
auditory impairment remains untreated, it may impact on patient communication and
rehabilitation after stroke. Offering a comprehensive audiological assessment to all
stroke patients would be both costly and time-consuming. A brief hearing screening is
thus required.
Objective: The aim of this study was to determine whether a two-tiered hearing
screening approach, with use of a handheld hearing screener and two validated hearing
questionnaires could be used as a hearing screening for peripheral hearing loss and
CAPD in stroke survivors. The sensitivity and specificity of the screening method
was analyzed.
Methods: This was a prospective study conducted in a tertiary neurology hospital.
Forty-two consecutive stroke patients were recruited and tested within 3–12 months
post-onset of their stroke. Three screening tools for the identification of hearing
impairment were evaluated in this study: A handheld hearing screener for determination
of peripheral audiometric hearing loss and two validated questionnaires (The Amsterdam
Inventory Auditory for Disability (AIAD) and the Hearing Handicap Inventory for Elderly
(HHIE) questionnaires) for determination of peripheral hearing loss and/or CAPD.
Results: The hearing screener had a sensitivity of 92. 59% detecting a hearing loss
and specificity of 100%. The greatest test accuracy in identifying a central auditory
processing type hearing impairment in stroke patients was found when the handheld
hearing screener and the AIAD questionnaire were combined.
Conclusion: This study is a first step toward addressing the complex auditory needs
of stroke survivors in a systematic manner, with the ultimate aim to support their
communication needs and long-term recovery and wellbeing.
Registration: Project Identification number 11/0469 and REC ref 11/LO/1675.
Keywords: stroke, hearing loss, hearing screening, central auditory processing disorder, hearing questionnaires
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INTRODUCTION
Stroke can affect all levels of the auditory pathway from the
hearing organ to the cortex and manifest with deficits
in audiometric thresholds and/or more complex central
auditory processing disorder (CAPD) with perceptual
difficulties in speech, sound recognition, and localization
(1–3). However, auditory impairments in stroke patients may
remain undocumented, as these may not become obvious on
superficial evaluation (4) and can have adverse effects on patient
communication and rehabilitation after stroke (5). Hearing loss
doubles the risk for dementia after vascular factors are controlled
and is one of a few modifiable risk factors for dementia with a
population attributable fraction (i.e., percentage reduction in
new cases over a given time) of 9.1% (6). Stroke increases the risk
for vascular dementia (7) and is associated with accelerated post-
stroke cognitive decline (8). Stroke survivors with different types
of auditory impairments may thus be even more vulnerable to
cognitive decline than the general population or stroke survivors
without hearing impairments. There are several management
options for the remediation of auditory impairments and related
deficits (peripheral and/or central), including hearing aids and
assistive listening devices. Early identification and remediation
of auditory impairments and deficits in stroke survivors may not
only help improve speech perception (9), communication and
overall social engagement (10) but may potentially preserve their
cognitive function long term (11).
Offering a comprehensive audiological assessment to all
stroke patients would be both costly and time-consuming.
A preliminary brief screening assessment to reliably identify
perceived auditory difficulties among stroke survivors is thus
required. To date, only four studies have attempted to screen
hearing in a stroke population (4, 12–14). Edwards et al.
(4) employed a non-standardized consonant vowel syllable
repetition test as a hearing screening tool to determine whether
screening would detect cognitive and sensory impairment in
patients with acute stroke more efficiently than the standard
clinical practice that relies on patient report. They reported that
42% of stroke patients failed the hearing-screening test, with
86% of these unidentified prior to the screening. However, the
sensitivity and specificity of the tool they used is unknown.
O’Halloran et al. (14) screened the hearing of 49 stroke patients
at bedside using a portable audiometer with noise occluding
headphones. They identified 79% of stroke patients as having a
mild or greater hearing impairment in the acute stage of stroke.
The numbers above could be underestimated or exaggerated due
to methodological issues, such as testing conducted in the acute
stage, testing in noisy wards, etc. Formby et al. (12) similarly
measured pure-tone air conduction thresholds in 243 stroke
patients in a rehabilitation ward using a portable audiometer.
None of these studies assessed for the presence of CAPD, which
may also be common and associated with significant disability
(2, 3). At present, there is no such validated hearing screening
protocol in stroke survivors that aims to identify both peripheral
hearing loss and CAPD, since stroke patients may have both types
of deficits (3).
Handheld hearing screeners are used to identify the possibility
of an individual presenting with peripheral hearing loss who
requires full audiological assessment (15). In addition to the
screening audiometer, self-report hearing instruments may
identify additional auditory perceptual deficits to pure tone
detection loss (1, 2) with low cost implications (16).
The primary purpose of this study was to determine whether
a two-tiered screening approach, with use of a handheld hearing
screener and two validated hearing questionnaires at the 3-month
follow up post discharge from a stroke unit could be used as a
hearing screening strategy to facilitate early identification and
appropriate referral of auditory impaired stroke patients.
METHODS
Study Design
This was a study of diagnostic accuracy using sensitivity and
specificity. The study was a prospective study where the data
collection was planned before the index test and reference
standard were performed.
Participants
The Ethics Committee of the National Hospital for Neurology
and Neurosurgery (NHNN) approved the Hearing Evaluation
and Auditory Rehabilitation after Stroke (HEARS) study (Project
Identification number 11/0469 and REC ref 11/LO/1675).
We obtained written informed consent from all the stroke
participants. Fifty consecutive stroke patients were recruited and
tested at the department of Neuro-otology, NHNNQueen Square
London, within 3–12 months post-onset stroke, since auditory
impairments are stable at that point (17). Because we aimed
to validate screening for both peripheral and central auditory
disorders, patients were excluded when they had a severe or
greater hearing loss (>70 dB HL) (18) or cognitive impairments
(Montreal Cognitive Assessment: MoCA ≤25) (19). Inclusion
criteria were (1) age between 18 and 80 years and (2) clinical
history of stroke verified by magnetic resonance imaging (MRI)
of the brain. Exclusion criteria were (1) severe aphasia, (2)
cognitive impairment as shown on the MoCA with a score
<25, (3) significant psychiatric illnesses, (4) other neurological
disorders (except stroke), and (5) severe concurrent medical
illnesses. With the exception of the MoCA, presence or absence
of the other criteria was judged on the basis of information
from the participnts’ clinical notes. All participants had had
a brain MRI 48 h after the stroke. The scan was reviewed by
the consultant stroke neurologist (DW) and classified in terms
of stroke etiology (ischemic/haemorrhagic) and site of lesions
(cortical/subcortical/brainstem). See Table 1 for details.
The screening tests were completed for each subject in a
random order during a single visit, before the administration
of the full audiological assessment which aimed to identify and
categorize the patient’s auditory profile into one of the following:
(1) normal, (2) peripheral hearing loss (cochlea to auditory
nerve), (3) CAPD (brainstem to cortex and beyond) (20, 21),
and (4) combination (peripheral hearing loss and CAPD). The
handheld screener test was performed by NU who at the time of
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TABLE 1 | Patients and stroke characteristics.
Case Age Sex Days since
stroke
Type of stroke Side Hearing impairment Handheld
hearing screener
HHIE
total
AIAD
total
1 43 M 108 Ischemic subcortical Right CAPD Pass 0 69
2 23 M 240 Ischemic cortical Left CAPD Pass 0 60
3 76 M 142 Ischemic brainstem Left Peripheral Fail 0 84
4 68 M 98 Ischemic subcortical Right Peripheral Fail 18 82
5 76 M 110 Ischemic cortical Right Peripheral and CAPD Fail 50 65
6 63 M 138 Ischemic cortical/subcortical Right Peripheral and CAPD Fail 0 84
7 53 F 170 Ischemic subcortical Left Normal Pass 0 84
8 32 M 158 Haemorrhagic brainstem Bilateral Normal Pass 0 84
9 66 M 162 Ischemic brainstem Right Peripheral Fail 2 79
10 31 M 102 Ischemic cortical Right CAPD Pass 20 73
11 72 F 112 Ischemic subcortical Bilateral Peripheral Fail 46 62
12 60 M 129 Ischemic cortical Left Normal Pass 0 81
13 73 M 92 Ischemic brainstem Right Peripheral and CAPD Fail 8 71
14 59 M 97 Ischemic subcortical Right Peripheral Fail 2 69
15 44 M 163 Ischemic cortical Left CAPD Pass 0 84
16 67 M 128 Ischemic subcortical Left Peripheral and CAPD Fail 10 78
17 57 M 97 Ischemic cortical Left CAPD Pass 8 80
18 75 F 267 Ischemic cortical Left Peripheral Fail 42 67
19 80 F 217 Ischemic cortical Right Peripheral Fail 22 73
20 54 F 307 Ischemic cortical Right Peripheral and CAPD Fail 18 37
21 53 M 140 Haemorrhagic cortical Left Peripheral Pass 0 84
22 77 M 103 Ischemic cortical Right Peripheral and CAPD Fail 2 44
23 63 M 143 Ischemic brainstem Right Peripheral Fail 26 71
24 46 M 237 Ischemic cortical and subcortical Right CAPD Pass 20 59
25 71 M 111 Ischemic cortical Right Peripheral and CAPD Fail 0 84
26 52 M 94 Ischemic cortical and subcortical Left Peripheral Fail 50 55
27 63 F 174 Ischemic cortical Left Peripheral and CAPD Pass 0 84
28 74 M 204 Ischemic brainstem Left Normal Pass 0 84
29 74 M 136 Ischemic subcortical and brainstem Right Peripheral and CAPD Fail 4 64
30 70 M 118 Ischemic cortical Left Peripheral and CAPD Fail 0 74
31 65 M 158 Ischemic subcortical and brainstem Right Peripheral and CAPD Fail 0 71
32 74 M 166 Ischemic cortical and subcortical Left Peripheral and CAPD Fail 64 56
33 65 M 169 Haemorrhagic subcortical Right Peripheral and CAPD Fail 40 71
34 70 M 105 Ischemic cortical and subcortical Right Peripheral Fail 72 63
35 48 M 337 Ischemic cortical Left Normal Pass 0 82
36 43 F 190 Haemorrhagic brainstem Right CAPD Pass 8 67
37 44 M 125 Ischemic cortical Right Peripheral and CAPD Fail 10 80
38 61 M 360 Ischemic cortical Left Peripheral and CAPD Fail 40 63
39 36 M 317 Ischemic cortical Left CAPD Pass 0 56
40 32 M 301 Ischemic cortical Right CAPD Pass 42 51
41 54 F 334 Haemorrhagic brainstem Left Peripheral and CAPD Fail 90 48
42 37 F 160 Ischemic cortical and subcortical Right Normal Pass 0 84
the study had had no previous audiological training other than
the theoretical background of her MSc; the questionnaires were
filled in by the patients without any support by the research team;
NK conducted the remaining assessments.
Below we describe the definition and diagnostic criteria for
each category.
Definition of Peripheral Hearing Impairment and
Diagnostic Criteria
Threshold assessment was made at 250, 500, 1,000, 2,000, 4,000,
6,000, and 8,000Hz, and a pure-tone audiometry (PTA) average
was calculated. The severity of hearing loss was determined
using the British Society of Audiology audiometric descriptors
(20). Also, high-frequency hearing loss was defined as the air-
conduction average of frequencies 4, 6, and 8 kHz exceeding 20
dB HL. Mild hearing loss was defined as PTA ≥20 and ≤40
dB HL, moderate (41–70 dB HL), severe (71–95 dB HL), and
profound (>95 dB HL).
The peripheral hearing loss (attributed to pathology in the
middle ear, cochlear, and/or the distal portion of auditory
nerve) was defined as (a) “cochlear type” hearing loss:
abnormal pure-tone average, reduced or absent Transient-evoke
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otoacoustic emission (TEOAEs), present and normal acoustic
reflex threshold (ART), and normal auditory brainstem response
(ABR) or normal interwave interval ABR (22); “neural type”
hearing loss, that is, consistent with VIIIth nerve damage (23):
normal or raised PTA average, normal TEOAEs, or delayed I–III
or I–V interwave interval or absent wave I (showing the damage
to the distal portion of auditory nerve) (22) and/or abnormal
ART with inverted or vertical pattern (24).
Definition of CAPD and Diagnostic Criteria
The definition of CAPD adopted by this study was according to
the technical report of the American Speech-Language-Hearing
Association (ASHA) Working Group (2005) (21), “deficits in
the perceptual processing of auditory information in the central
nervous system and the neurobiological activity that underlies
that processing and gives rise to electrophysiological auditory
potentials.” A CAPD diagnosis was based on the presence of
at least two central auditory nervous system test abnormalities,
in electrophysiological/electroacoustical tests (ABR, ART) and
in behavioral auditory processing tests including the gaps in
noise (GIN) (25) and the perceptual spectral property processing,
and apperceptive processing tests of the Queen Square Tests
of Auditory Cognition (QSTAC) test battery (that also includes
a semantic processing test) (26). For the CAPD diagnosis test
deficits should be present in at least one ear, with >1 test
abnormality being in a behavioral auditory processing test and
with the following additional considerations:
1. The electrophysiological/electroacoustic test abnormality was
not attributable to the presence of hearing loss (see ABR and
ART criteria).
2. A semantic test abnormality in the QSTAC without
abnormalities in the perceptual spectral and/or apperceptive
tests of the same battery was not considered to be evidence of
disordered auditory processing.
Definition of Combination Hearing Impairment
(Peripheral Hearing Loss and CAPD) Diagnostic
Criteria
For the purpose of this study, if CAPD and/or an isolated
brainstem type ABR and ART test abnormality was detected in
the presence of peripheral hearing loss, we defined the pattern as a
combination (peripheral and central) type auditory impairment.
Test Method
Screening Tools
Three screening tools for the identification of hearing
impairment were evaluated in this study:
• Handheld hearing screener (ROTO, Otovation) for
determination of peripheral audiometric hearing loss.
• Two validated self-reported hearing questionnaires for
determination of hearing disability.
– Themodified Amsterdam Inventory Auditory for Disability
(AIAD) questionnaire (27): The AIAD has 28 questions
and assesses auditory disability in five key domains:
intelligibility of speech in noise; intelligibility of speech in
quiet; auditory localization; recognition of sound; detection
of sound. We chose the modified AIAD questionnaire for
our study, as Neijenhuis et al. (28) had administered it to
patients with auditory processing disorders and for whom
the scores for speech intelligibly and localization items
on AIAD were worse in comparison to those of controls.
The inventory was designed to identify factors related to
hearing disability that affected the individual in daily life
and to assess the impact the disability had on quality of life.
The response scale consists of “almost always” (3 points),
“frequently” (2 point), “occasionally” (1 point), and “almost
never” (0 point). A lower score indicates a greater disability;
a score of 84 corresponds to no hearing disability at all.
– The Hearing Handicap Inventory for Elderly (HHIE)
questionnaire (29): The HHIE is a self-assessment
questionnaire of hearing handicap comprising 25 items.
Of them, 13 deal with emotional aspects (E), and 12 deal
with social and situational aspects (S). For each item or
situation, subjects are asked to give one of the following
responses: “yes” (4 points); “sometimes” (2 points), or “no”
(0 point). Scores for the total scale range from 0, suggesting
no perceived handicap, to 100, indicating significant
perceived handicap.
Screening Tools Procedure
The screening tests were performed at the department of neuro-
otology (NHNN), in a quiet but not soundproofed test room
situated next to the outpatient clinic rooms. This room was free
of visual and auditory distractions and similar to the clinic rooms
of the NHNN stroke follow-up clinic, with the same levels of
ambient noise level that did not exceed 50 dBA and was most
commonly around 41–42 dBA, as measured with a sound level
meter (SL-4010 LUTRON Digital Sound Level Meter).
All the screening tests (handheld hearing screener, AIAD
and HHIE questionnaires) were completed for each subject in a
randomized order during a single visit before the administration
of the full audiological assessment.
For the handheld hearing screener test the participants were
asked to respond according to the British Society of Audiology
recommended procedure for PTA (20). This test took 5min
with instructions.
The AIAD and HHIE questionnaires, that were administered
to the stroke patients as self-reported questionnaires, took under
10min per questionnaire for completion.
Criteria for “Gold Standard”
For the handheld hearing screener, the pure-tone audiogram
was established as the “gold standard” according to the ASHA
“guidelines for audiologic screening” (15).
For the hearing questionnaires, information from different
comprehensive audiological tests was combined to construct the
“reference standard outcome” (i.e., the best available method
of categorizing participants as having or not having the target
condition). All patients received the same set of audiological
tests that are described below in brief (more detailed description
can be found in Supplementary Data Sheet 1). To calculate the
sensitivity and specificity of the hearing questionnaires, the cut-
off scores of the HHIE and the AIAD were compared against the
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hearing types (reference standard outcome) i.e., normal hearing,
peripheral hearing loss, combination and CAPD.
Pass and Fail Criteria for Hearing Screening Tools
• Handheld hearing screener: We screened hearing using the
protocol recommended by ASHA (15), presenting pure-tones
at 25 dB HL at the frequencies of 1,000, 2,000, and 4,000Hz.
Fail at least one frequency across both ears (Fail), or pass all
frequencies in both ears (Pass).
• The diagnostic performance of HHIE questionnaire was
compared against two different definitions of hearing loss:
(a) the criteria of Ventry and Weinstein study (30); patients
considered having hearing impairment if they had a loss at
40 dB HL for either the 1,000 or 2,000Hz frequencies in both
ears or they had a 40 dB HL loss at 1,000 and 2,000Hz in one
ear. (b) Criteria of Goldstein study (31); patients considered
hearing impaired if the average hearing loss at 1,000, 2,000,
and 4,000Hz was≥25 dBHL in the better ear. If the total score
≤16, then no hearing disability was identified; if the total score
was 17 or more, the subject was considered to have a hearing
disability (31).
• AIAD questionnaire: Hearing disability was defined by the
criteria of Meijer et al. (27). Pass was defined as AIAD scores
ranging from 64 to 84 (no disability), and fail was defined as a
total score of <64.
• Combined handheld hearing screener and AIAD
questionnaire for identifying CAPD: For those with CAPD,
auditory disability was defined according to the criteria of
departmental normative data for CAPD in conjunction with
Bamiou’s studies in CAPD and stroke patients (2, 32): Fail
if the total score of the AIAD was ≤58, or if the total score
of the AIAD was >58 but the localization sub-score was
≤10 and/or the speech in noise sub-score was ≤7 AND pass
hearing screener.
“Gold Standard” Audiological Assessment
Patients were tested in a sound-treated booth with standard
clinical procedures including PTA (to determine hearing
thresholds), tympanometry and acoustic reflexes threshold to
determine middle ear or auditory nerve to lower brainstem
problems), transient-evoked otoacoustic emissions (to assess
cochlear function), auditory-evoked brainstem responses (to
assess auditory nerve & brainstem). A non-verbal auditory
processing test battery was used to assess temporal resolution
[Gaps-in-noise] (25) and early perceptual, apperceptive and
semantic auditory processing QSTAC (26). These tests were
chosen on the basis of existing professional guidelines for the
evaluation of peripheral hearing loss and CAPDs. All these tests
and procedures are described in Supplementary Data Sheet 1.
Analysis
To evaluate the accuracy of the screening tools for the diagnosis
of hearing impairment, calculations of sensitivity, specificity,
positive predictive value (PPV), and negative predictive value
(NPV) were performed using the “gold standard” described
in Methods. Sensitivities were calculated as the proportions of
persons with hearing impairment correctly identified by the tests,
TABLE 2 | Analysis of responses to hearing screening in both ears (84 ears),
considering the interpretation according to ASHA protocol (1997).
Estimate
(%)
95% confidence interval (exact)
Lower limit (%) Upper limit (%)
Sensitivity 92.59 75.71 99.09
Specificity 100.00 78.20 100.00*
Positive predictive value 100.00 86.28 100.00*
Negative predictive value 88.24 63.56 98.54
*One-sided confidence interval.
TABLE 3 | Sensitivity, specificity, positive predictive value, and negative predictive
value of HHIE.
Estimate
(%)
95% confidence interval (exact)
Lower limit (%) Upper limit (%)
Sensitivity 44.44 27.94 61.90
Specificity 100.00 54.07 100.00*
Positive predictive value 100.00 79.41 100.00*
Negative predictive value 23.08 8.97 43.65
*One-sided confidence interval.
while specificities were calculated as the proportions of persons
without hearing impairment correctly identified by the tests. PPV
is the probability that subjects with a positive screening test truly
have the disease, and NPV is the probability that subjects with a
negative screening test truly do not have the disease.
RESULTS
Participants
Data from 42 stroke patients were obtained for all screening
protocols (for the handheld hearing screener, n = 84 ears). The
age ranged from 23 to 80 years old with an average of 58.19
years old (SD = 15.06). Days since stroke ranged between 92
and 360 days (mean = 171.88, SD = 76.42). The stroke was
haemorrhagic in six and ischemic in 36. SeeTable 1 for additional
stroke characteristics.
Test Results
Accuracy of Handheld Hearing Screener
Data were analyzed for both ears. The hearing screener had
a sensitivity of 92.59% for detecting a peripheral hearing loss
(Table 2) and specificity of 100%. PPV of 100% and NPV
of 88.24%.
Accuracy of Self-Reported HHIE Questionnaire
The HHIE questionnaire had a low sensitivity of 44.44% and
specificity of 100% for peripheral hearing loss, PPV of 100% but
NPV of 23.08% (Table 3).
Accuracy of Self-Reported AIAD Questionnaire
The AIAD questionnaire had a sensitivity of 36.11% for detecting
peripheral hearing loss Specificity of 100%. PPV of 100% and
NPV of 20.69% (Table 4).
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TABLE 4 | Sensitivity, specificity, positive predictive value, and negative predictive
value of AIAD.
Estimate
(%)
95% confidence interval (exact)
Lower limit (%) Upper limit (%)
Sensitivity 36.11 20.82 53.78
Specificity 100.00 54.07 100.00*
Positive predictive value 100.00 75.29 100.00*
Negative predictive value 20.69 7.99 39.72
*One-sided confidence interval.
TABLE 5 | Sensitivity, specificity, positive predictive value, and negative predictive
value of combined handheld hearing screener and AIAD.
Estimate
(%)
95% confidence interval (exact)
Lower limit (%) Upper limit (%)
Sensitivity 50.00 15.70 84.30
Specificity 88.89 51.75 99.72
Positive predictive value 80.00 28.36 99.49
Negative predictive value 66.67 34.89 90.08
Combining the Handheld Hearing Screener and
Self-Reported AIAD Questionnaire for
Identifying CAPD
The greatest test accuracy in identifying a CAPD type hearing
impairment in stroke patients was found when the handheld
hearing screener and the AIAD questionnaire were combined.
The combined use of AIAD and handheld screener questionnaire
had a sensitivity of 50%, specificity of 88.89%, PPV of 80%, and
NPV of 66.67% (Table 5).
DISCUSSION
This is the first study to assess the efficacy of a simple hearing
screening program in the stroke population for both peripheral
hearing loss and central auditory impairments. Of the three tools
used, the handheld hearing screener had the highest sensitivity
(93%) and specificity (100%) in detecting a mild or greater
hearing loss in stroke patients, similar to previous studies on
non-neurological populations (33, 34). Such screening does not
require audiology expertise and takes approximately <5min
(35). Our results indicate that the handheld hearing screener is
a valid, reliable and sensitive instrument for detecting significant
audiometric hearing loss in stroke patients when performed in a
clinical setting.
The HHIE yielded low sensitivity (44%) and NPV (23%)
but optimal specificity and PPV (100%) for the detection of
peripheral hearing loss. Low sensitivity and low NPV indicate
that stroke patients tend to under report hearing disability.
Several studies show that the HHIE questionnaire is effective
for identification of moderate to severe hearing loss (29, 36–38)
rather than mild hearing loss (36, 39). The low sensitivity yielded
in our study may partly reflect the inclusion of those with mild
hearing loss and/or CAPD in our cohort.
The AIAD questionnaire gave similar results to the HHIE
when used to screen for peripheral hearing loss after stroke. For a
cut-off value of >64 (27), the AIAD yielded low sensitivity (36%)
and NPV (21%) but high specificity (100%) and PPV (100%).
The poor sensitivity for detection of peripheral hearing loss
of both AIAD and HHIE questionnaires could be attributed
to the fact that these measure self-reported auditory disability,
which may arise due to impairment at any level of the auditory
pathway. In addition, PTA results do not entirely correspondwith
self-reported hearing loss (36).
To this end, and toward the detection of central auditory
deficits corresponding to self-reported auditory difficulties,
combined use of the handheld hearing screener and AIAD, gave
the best results with a sensitivity of 50% and a high specificity of
89%, PPV of 80%, and NPV of 67%. Similar to the HHIE results
for peripheral hearing loss, a significant proportion of stroke
patients with a central auditory impairment failed to report it.
However, the high specificity showed the ability of the auditory
questionnaires to correctly identify patients without central
auditory impairments. Their use will potentially limit the number
of unnecessary referrals for further central auditory evaluations.
The results of our study, albeit preliminary, are promising,
in that the handheld hearing screener use yielded reliable
information about patients requiring detailed assessment for
peripheral hearing loss. Furthermore, the addition of the AIAD
self-report measure identified a further proportion of patients
in need of further central auditory evaluation, who might not
routinely receive such assessment otherwise.
This protocol may provide useful information for the
rehabilitation team to help identify patients with high levels
of perceived deficits and disability who need additional
investigation and input on a case-by-case basis. In Figure 1,
we propose a schematic representation of a hearing screening
protocol for stroke patients in the chronic stage of stroke.
Clinical implication of the present study is noteworthy.
The National Institute for Health and Care Excellence in
the UK recommends performing a full medical assessment
of the person with stroke including functional ability and
communication. However, hearing assessment is not featured
in this guideline. Uncorrected hearing loss may affect outcome
of speech and language assessment and related therapies
(40), and impact on functional recovery after stroke (5). In
addition, individuals with hearing loss have an increased rate
of developing dementia and more rapid cognitive decline
than their non-hearing-impaired counterparts (41). Over 50%
of stroke patients exhibit cognitive impairment post-stroke
(42). Therefore, secondary preventive strategies to avert post-
stroke cognitive decline and a transition into dementia is
urgently needed for this population (42). Appropriate auditory
rehabilitation interventions (9, 43) may reduce the potential
negative effects of hearing impairment in stroke patients. In
summary, early identification of hearing impairment for optimal
outcomes from post-stroke rehabilitation is imperative and the
current clinical guidelines could benefit from promoting hearing
screening in stroke units.
The findings of this preliminary study will require
corroboration and development in further pragmatic
studies involving larger cohorts, within stroke units and
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FIGURE 1 | A schematic representation of a hearing screening protocol for stroke patients.
possibly including those with severe aphasia and/or cognitive
impairments. However, this study is a first step toward addressing
the complex auditory needs of stroke survivors in a systematic
manner, with the ultimate aim to support their communication
needs, long-term recovery and wellbeing, and thus possibly delay
onset of post stroke dementia (6).
To our knowledge, this is the first study to assess the
efficacy of a low-cost hearing screening program in the stroke
population for both peripheral hearing loss and central auditory
impairments. Of the three tools used, the handheld hearing
screener had the highest sensitivity (93%) and specificity (100%)
in detecting a mild or greater hearing loss in stroke patients,
similar to previous studies on non-neurological populations (33,
34). Such screening does not require audiology expertise and
takes∼3min (35). Our results indicate that the handheld hearing
screener is a valid, reliable, and sensitive instrument for detecting
amild or greater audiometric hearing loss in stroke patients when
performed in a clinical setting.
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